Invention Publication
- Patent Title: PHARMACEUTICAL COMPOSITIONS COMPRISING LTV-17 AND BETA-LACTAMASE INHIBITORS AND THEIR USE AS ANTIBACTERIAL AGENTS
-
Application No.: US17984553Application Date: 2022-11-10
-
Publication No.: US20230149368A1Publication Date: 2023-05-18
- Inventor: Sameeh M. SALAMA , Samarendra N. MAITI , Renata JANKOWSKA
- Applicant: FEDORA PHARMACEUTICALS INC.
- Applicant Address: CA Edmonton
- Assignee: FEDORA PHARMACEUTICALS INC.
- Current Assignee: FEDORA PHARMACEUTICALS INC.
- Current Assignee Address: CA Edmonton
- Main IPC: A61K31/427
- IPC: A61K31/427 ; A61P31/04 ; A61K31/4188
Abstract:
Pharmaceutical combinations of LTV-17 (I), a lactivicin derivative, and β-lactamase inhibitors are provided, wherein the combinations comprise antibacterial agents suitable for use in the treatment or prevention of bacterial infections.
Public/Granted literature
Information query
IPC分类:
